Skip to main content
. 2011 Dec 15;2(6):114–122. doi: 10.4291/wjgp.v2.i6.114

Table 3.

Overview of the combined gene and cell therapy based treatment strategies for inflammatory bowel diseases as discussed in this review

Applied strategy Viral vector used Reference for viral vector used Status of development Reference for status of development
Combined gene and cell therapy Ex vivo generated Treg/Tr1 Retrovirus [113,115] Preclinical [113,115]
T cell receptor transgenic Treg Retrovirus [116] Preclinical [116]

The status of development refers to research which has already been performed. Treg: CD4+CD25highFOXP3+ regulatory T cell; Tr1: Type 1 regulatory T cell.